DaVita Inc. Enhances Kidney Care Through Innovation and Comprehensive Patient Support

DaVita Inc.'s Commitment to Transformative Kidney Care

DaVita Inc., a prominent player in the kidney care sector, remains focused on improving the quality of life for patients suffering from kidney disease. With over 25 years of dedicated service, the company is at the forefront of comprehensive kidney care, addressing patients' needs across all stages of their health journey. From efforts to slow the progression of kidney disease to facilitating successful transplants, DaVita presents an integrated approach to treatment that emphasizes both proactive and reactive healthcare strategies. This holistic philosophy is not only vital for patient outcomes but also essential in advancing the overall standard of care within the kidney treatment community.

As of December 31, 2025, DaVita serves approximately 295,000 patients through an expansive network of 3,242 outpatient dialysis centers. A significant majority, 2,657, of these centers are located in the United States, while the rest are distributed across 14 countries. This global reach positions DaVita as a leader in the kidney care industry, allowing the company to leverage its extensive experience and insights to deliver tailored treatments that reflect local needs and conditions. By focusing on accessibility and quality, DaVita aims to reduce preventable hospitalizations and improve mortality rates, offering hope to patients and families affected by kidney-related health issues.

DaVita is also committed to innovation and collaboration within the kidney care community. The company's efforts encompass a wide range of care delivery settings, including home care and skilled nursing facilities, further ensuring that patients have access to high-quality care wherever they are. By harmonizing healthcare delivery across various environments, DaVita strives to raise care standards, foster community partnerships, and ultimately empower patients through education and shared decision-making. This vision is encapsulated in their mission to redefine kidney care, as the company continues to invest in initiatives that promise to transform patient experiences and outcomes.

In tandem with its operational advancements, DaVita's Chief Financial Officer, Joel Ackerman, and Vice President of Investor Relations, Nic Eliason, are set to address attendees at the TD Cowen’s 46th Annual Health Care Conference on March 2, 2026. Their participation underscores the company's ongoing commitment to transparency and engagement with stakeholders, reinforcing the strategic importance of communication in achieving company goals.

For more insights into DaVita's services and initiatives, interested parties can visit their official website at DaVita.com/About. This resource offers a wealth of information about the company's programs, patient care options, and ongoing efforts to advance kidney healthcare worldwide.